MiR-183-5p protects rat hearts against myocardial ischemia/reperfusion injury through targeting VDAC1

Biofactors. 2020 Jan;46(1):83-93. doi: 10.1002/biof.1571. Epub 2019 Oct 16.

Abstract

MicroRNAs have been reported to be implicated in myocardial ischemia/reperfusion (I/R) injury. The purpose of this study was to investigate the effect of miR-183-5p on I/R injury. Overexpression of miR-183-5p by agomiR transfection alleviated cardiac dysfunction and significantly reduced the infarct size in rats with myocardial I/R. MiR-183-5p also alleviated myocardial apoptosis with reduced apoptotic cells and lower levels of apoptosis associated proteins. in vitro experiments were conducted on rat H9c2 cells treated with anoxia/reoxygenation (A/R). Annexin V/propidium iodide (PI) staining and flow cytometry reported that the ratio of apoptotic cells decreased by miR-183-5p transfection before A/R treatment. Moreover, according to binding sequence prediction and Dual luciferase reporter assay, we explored that voltage-dependent anion channel 1 (VDAC1), which aggravates myocardial injury and apoptosis reported in our former research, was a target of miR-183-5p. In conclusion, miR-183-5p can efficiently attenuate I/R injury and miR-183-5p may exert its effect through repressing VDAC1 expression.

Keywords: H9c2 cells; ischemia/reperfusion injury; microRNA-183-5p; rat; voltage-dependent anion channel 1.

MeSH terms

  • Animals
  • Apoptosis / genetics
  • Disease Models, Animal
  • Male
  • MicroRNAs / genetics
  • MicroRNAs / metabolism*
  • Myocardial Reperfusion Injury / genetics
  • Myocardial Reperfusion Injury / metabolism
  • Myocardial Reperfusion Injury / prevention & control*
  • Protective Agents / metabolism*
  • Rats
  • Rats, Wistar
  • Voltage-Dependent Anion Channel 1 / antagonists & inhibitors*
  • Voltage-Dependent Anion Channel 1 / genetics

Substances

  • MicroRNAs
  • Protective Agents
  • Vdac1 protein, rat
  • Voltage-Dependent Anion Channel 1